CCL2 mitigates cyclic AMP-suppressed Th2 immune response in human dendritic cells

Byoungjae Kim; Ji Woo Yeon; Ji Hyung Lee; Hyun Ji Lee; Junhyoung Byun; Kijeong Lee; Eyal Raz; Sang Hag Lee; Seung Kuk Baek; Tae Hoon Kim

doi:10.1111/all.14284

CCL2 mitigates cyclic AMP-suppressed Th2 immune response in human dendritic cells

Byoungjae Kim, Ji Woo Yeon, Ji Hyung Lee, Hyun Ji Lee, Junhyoung Byun, Kijeong Lee, Eyal Raz, Sang Hag Lee, Seung Kuk Baek, Tae Hoon Kim

Department of Biomedical Sciences

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Article number	ALL14284
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	75
Issue number	8
DOIs	https://doi.org/10.1111/all.14284
Publication status	Published - 2020 Aug 1

Keywords

CCL2
Gnas mice
allergic rhinitis
cAMP
dendritic cells

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1111/all.14284

Cite this

@article{bda6021e37f04c6aa7bf183254cd93fd,

title = "CCL2 mitigates cyclic AMP-suppressed Th2 immune response in human dendritic cells",

keywords = "CCL2, Gnas mice, allergic rhinitis, cAMP, dendritic cells",

author = "Byoungjae Kim and Yeon, {Ji Woo} and Lee, {Ji Hyung} and Lee, {Hyun Ji} and Junhyoung Byun and Kijeong Lee and Eyal Raz and Lee, {Sang Hag} and Baek, {Seung Kuk} and Kim, {Tae Hoon}",

note = "Funding Information: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF2016R1D1A1A02937362, 2018R1D1A1A09083263), Science, and Technology and the Ministry of Science, ICT, & Future Planning (NRF-2017R1A2B2003575); the Korea Health Technology R&D Project (HI14C0748, HI17C0387) through the Korea Health Industry Development Institute (KHIDI) by the Ministry of Health & Welfare; the Clinical Trial Center of Korea University Anam Hospital (I1502411); and Korea University Medical Center and Anam Hospital, Seoul, Republic of Korea (K1621481, K1814581). This research was also supported by a Korea University grant and an NIH grant (HL-141999, AI-125860). Funding Information: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF2016R1D1A1A02937362, 2018R1D1A1A09083263), Science, and Technology and the Ministry of Science, ICT, & Future Planning (NRF‐2017R1A2B2003575); the Korea Health Technology R&D Project (HI14C0748, HI17C0387) through the Korea Health Industry Development Institute (KHIDI) by the Ministry of Health & Welfare; the Clinical Trial Center of Korea University Anam Hospital (I1502411); and Korea University Medical Center and Anam Hospital, Seoul, Republic of Korea (K1621481, K1814581). This research was also supported by a Korea University grant and an NIH grant (HL‐141999, AI‐125860).",

year = "2020",

month = aug,

day = "1",

doi = "10.1111/all.14284",

language = "English",

volume = "75",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - CCL2 mitigates cyclic AMP-suppressed Th2 immune response in human dendritic cells

AU - Kim, Byoungjae

AU - Yeon, Ji Woo

AU - Lee, Ji Hyung

AU - Lee, Hyun Ji

AU - Byun, Junhyoung

AU - Lee, Kijeong

AU - Raz, Eyal

AU - Lee, Sang Hag

AU - Baek, Seung Kuk

AU - Kim, Tae Hoon

N1 - Funding Information: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF2016R1D1A1A02937362, 2018R1D1A1A09083263), Science, and Technology and the Ministry of Science, ICT, & Future Planning (NRF-2017R1A2B2003575); the Korea Health Technology R&D Project (HI14C0748, HI17C0387) through the Korea Health Industry Development Institute (KHIDI) by the Ministry of Health & Welfare; the Clinical Trial Center of Korea University Anam Hospital (I1502411); and Korea University Medical Center and Anam Hospital, Seoul, Republic of Korea (K1621481, K1814581). This research was also supported by a Korea University grant and an NIH grant (HL-141999, AI-125860). Funding Information: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF2016R1D1A1A02937362, 2018R1D1A1A09083263), Science, and Technology and the Ministry of Science, ICT, & Future Planning (NRF‐2017R1A2B2003575); the Korea Health Technology R&D Project (HI14C0748, HI17C0387) through the Korea Health Industry Development Institute (KHIDI) by the Ministry of Health & Welfare; the Clinical Trial Center of Korea University Anam Hospital (I1502411); and Korea University Medical Center and Anam Hospital, Seoul, Republic of Korea (K1621481, K1814581). This research was also supported by a Korea University grant and an NIH grant (HL‐141999, AI‐125860).

PY - 2020/8/1

Y1 - 2020/8/1

KW - CCL2

KW - Gnas mice

KW - allergic rhinitis

KW - cAMP

KW - dendritic cells

UR - http://www.scopus.com/inward/record.url?scp=85083300077&partnerID=8YFLogxK

U2 - 10.1111/all.14284

DO - 10.1111/all.14284

M3 - Letter

C2 - 32191339

AN - SCOPUS:85083300077

SN - 0105-4538

VL - 75

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 8

M1 - ALL14284

ER -

CCL2 mitigates cyclic AMP-suppressed Th2 immune response in human dendritic cells

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this